¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"relative field"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • relative risk
    »ó´ëÀ§Çèµµ
  • relative risk ratio
    »ó´ëÀ§Çèºñ
  • relative scotoma
    »ó´ë¾ÏÁ¡
  • relative sterility
    »ó´ëÀûºÒÀÓ
  • relative survival rate
    »ó´ë»ýÁ¸À²
  • relative valvular insufficiency
    »ó´ëÀûÆÇ¸·±â´ÉºÎÀü
  • resource based relative value scale
    ÀÚ¿ø±âÁØ»ó´ë°¡Ä¡µî±Þ
  • auditory field
    û°¢¹üÀ§, û¿ª
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • abutted field
    ÀÎÁ¢Á¶»ç¸é, Á¢ÃËÁ¶»ç¸é
  • B1 field gradient
    ȸÀüÀÚÀå±â¿ï±â
  • binocular field
    ¾ç¾È½Ã¾ß, µÎ´«½Ã¾ß
  • boost field
    Á¶»ç¿µ¿ª, Á¶»ç¸é
  • complex receptive field
    º¹ÇÕ¼ö¿ë¾ß
  • comprehensive field irradiation
    ±¤¹üÀ§Á¶»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • time dependent relative risk model
    ½Ã°£ÀÇÁ¸»ó´ëÀ§Çè¸ðµ¨
  • relative odds
    »ó´ëÀû´ëÀÀºñ
  • relative magnetic permeability
    »ó´ëÀÚ±âÅõ°ú·Â
  • relative refractory period
    »ó´ëºÒÀÀ±â
  • relative
    °ü°è
  • relative risk
    ºñ±³À§Çèµµ
  • relative scotoma
    »ó´ë¾ÏÁ¡
  • relative sterility
    »ó´ëÀûºÒÀÓ(Áõ)
  • relative biologic biologic effectiveness radiation
    »ó´ë»ý¹°ÇÐÀûÈ¿°ú
  • relative metabolic rate
    »ó´ë´ë»çÀ²
  • relative osteoid volume
    »ó´ëÀ¯°ñ·®
  • relative survival rate
    »ó´ë»ýÁ¸À²
  • resource based relative value scale
    Áö¿ø±âÁØ»ó´ë°¡Ä¡
  • abutted field
    ÀÎÁ¢Á¶»ç¸é, Á¢ÃËÁ¶»ç¸é
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • illumination, dark-field
    ¾Ï½Ã¾ßÁ¶¸í
  • point outside field
    Á¶»ç¿µ¿ª¹ÛÁöÁ¡
  • pulsed-field gel electrophoresis (PFGE)
    °£Çæ¾ß Àü±â¿µµ¿
  • radio-frequency field
    °íÁÖÆÄ ÀÚÀå
  • rectangular field of view (FOV)
    Á÷»ç°¢Çü ½Ã¾ß
  • haplodistinct relative
    ÀϹè¼öÀÌÁ¾°ü°è<--ģô>
  • haploidentical relative
    ÀϹè¼öµ¿Á¾°ü°è<--ģô>
  • hearing, relative
    »ó´ëÀû û°¨
  • radiation,relative biologic effectiveness(rbe)
    »ó´ëÀû(ºñ±³Àû)»ý¹°ÇÐÀûÈ¿°ú(ßÓÓßîÜ(ÝïÎòîÜßæÚªùÊîÜüùÍý)
  • relative accommodation
    »ó´ëÁ¶Àý(ÝïÎòðàï½).
  • relative acidosis
    »ó´ëÀû »êÁõ(ßÓÓßîÜß«ñø).
  • relative afferent pupillary defect
    »ó´ëÀû±¸½É¼ºµ¿°ø¿îµ¿Àå¾Ö
  • relative biologic effectiveness of radiation
    ¹æ»ç¼±ÀÇ»ó´ëÀû»ý¹°ÇÐÀûÈ¿°ú(Û¯ÞÒàÊ¡­ßÓÓßîÜßæÚªùÊîÜüùÍý)
  • relative biological effectiveness
    »ó´ëÀû »ý¹°ÇÐÀû È¿°ú(ßÓÓßîÜßæÚªùÊîÜüù
  • relative biological effectiveness
    »ó´ë»ý¹°ÇÐÀûÈ¿°ú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • relative centrifugal force
    ºñ¿ø½É·Â.
  • relative convergence
    »ó´ëÆøÁÖ(ÝïÎòÜßñÍ), »ó´ë´«¸ðÀ½
  • relative dispersion
    »ó´ëºÐ»ê(ßÓÓßÝÂߤ).
  • relative divergence
    ºñ±³°³»ê(ÝïÎòËÒߤ).
  • relative dose
    ºñ±³ Á¶»ç·®
  • relative dullness
    °æÅ¹À½°è(ÌîöúëåÍ£).
  • relative dullness
    °æÅ¹À½°è(ÌîöúëåÍ£)
  • relative error
    »ó´ë¿ÀÂ÷(Ë×ËÀËí̤).
  • relative flatness
    »ó´ëŹÀ½
  • relative frequency
    ºñ±³ºóµµ(ËÓË´Ë×̬).
  • relative growth
    »ó´ëÀû »ýÀå(ßÓÓßîÜßæíþ)
  • relative hearing
    »ó´ë(Àû) û°¨
  • relative hepatic dullness
    »ó´ë°£Å¹À½°è(ßÓÓßÊÜöúëåÍ£).
  • relative hepatic dullness
    »ó´ë°£Å¹À½°è(ßÓÓßÊÜöúëåÍ£)
  • relative humidity
    »ó´ë½Àµµ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • crystal field theory
    °áÁ¤ Àå·Ð(Ì¿ïÜíÞÖå)
  • electric field
    ÀüÀå(ï³íÞ) °ãÃþ(öµ)
  • field desorption mass spectrometry
    ÀåÅ»Âø Áú·®ºÐ±¤ÃøÁ¤¹ý (íÞ÷­ó·òõÕáÝÂÎÃö´ïÒÛö)
  • field effect
    ÀåÈ¿°ú(íÞüùÍý)
  • field flow fractionation
    Àå(íÞ)È帧 ºÐȹ¹ý(ÝÂüñÛö)
  • field inversion gel electrophoresis
    ÀåÀüµµ(íÞï´Óî) Á© Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • field ionization mass spectrometry
    Àå(íÞ) ÀÌ¿ÂÈ­(ûù) Áú·®ºÐ±¤ÃøÁ¤¹ý(òõÕáÝÂÎÃö´ïÒÛö)
  • field ion microscope
    Àå(íÞ) À̿ Çö¹Ì°æ(úéÚ°Ìð)
  • ligand field theory
    ¸®°£µåÀå(íÞ) ÀÌ·Ð(ìµÖå)
  • linear electric field effect
    ¼±Çü Àü±âÀåÈ¿°ú(àÊû¡ï³Ñ¨íÞüùÍý)
  • magnetic field
    ÀÚÀå(í¸íÞ)
  • pulsed-field gel electrophoresis
    ÆÞ½ºÀå(íÞ) Á© Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • sedimentation field flow fractionation
    ħ°­Àå(öØË½íÞ) È帧ºÐȹ¹ý(ÝÂüñÛö)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • field of view [=FOV]
    ¿µ»ó¿µ¿ª, ¿µ»ó¹üÀ§
  • field profile
    ÀÚÀåÃø¸é»ó
  • field size
    Á¶»ç¾ßÅ©±â
  • field strength
    ÀÚÀå¼¼±â, ÀÚÀå·Â
  • field survey
    ÇöÁöÁ¶»ç
  • FOV [=field of view]
    ¿µ»ó¿µ¿ª, ¿µ»ó¹üÀ§
  • fringe field
    ÁÖº¯¾ß
  • fringe magnetic field strength
    ÁÖº¯ÀÚÀå¼¼±â
  • geometric field distortion artifact
    ±âÇÏÇÐÀûÀÚÀå¿Ö°îÀΰø¹°
  • gradient magnetic field
    °æ»çÀÚ±âÀå
  • high field MR scanner
    °íÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
  • horizontal field magnet
    ¼öÆò¸éÀÚ¼®
  • in-field-of-view saturation band
    ¿µ»ó¿µ¿ª³»Æ÷È­´ë
  • intermediate field MR scanner
    ÁßµîÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
  • irradiation field
    ¹æ»ç¼±Á¶»ç¾ß
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EF ectopic focus; edema factor; ejection fraction; elastic fibril; electric field; elongation factor; e...
FA false aneurysm; Families Anonymous; Fanconi anemia; far advanced; fatty acid; febrile antigen; femor...
RAPD Relative Afferent Pupillary Defect
RBE Relative Biological Effectiveness
RR   1) Respiratory Rate
  2) Relative Risk; ºñ±³À§Çèµµ
    &n...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MRDR Modified Relative Dose Response
ROC Relative Operating Characteristic
RBAs Relative Binding Affinities
RBE Relative Biological Effect
RBE Relative Biological Effectiveness
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • dark-field microscope
    ¾Ï½Ã¾ß Çö¹Ì°æ
    ¾Ï½Ã¾ß Á¶¸í¹ý¿¡ ÀÇÇØ º¸ÅëÀÇ Çö¹Ì°æÀ¸·Î´Â º¸ÀÌÁö ¾Ê´Â ¹Ì¼¼ÇÑ ÀÔÀÚ¸¦ º¼ ¼ö ÀÖ´Â Çö¹Ì°æ. ÇÑ¿Ü Çö¹Ì°æÀ» ¸»Çϴµ¥, ¾Ï½Ã¾ß Á¶¸í°ú ±× Áý±¤ ·»Á »ç¿ëÇϹǷΠÀÌ¿Í °°ÀÌ ºÒ¸®±âµµ ÇÑ´Ù.
  • depository field
    ÷°¡ ¾ß
  • electromagnetic field
    ÀüÀÚÀå
    1. Àü±âÀå°ú ÀÚ±âÀåÀ» ÅëÆ²¾î ÁöĪÇÏ´Â ¸». 2. Àü±âÀå°ú ÀÚ±âÀåÀÌ ¼­·Î ¿¬°üµÇ¾î °°ÀÌ ³ªÅ¸³¯ ¶§ À̸£´Â ¸».
  • equivalent field
    µî°¡ Á¶»ç ¿µ¿ª
  • eye field
    ½Ã¾ß
  • far field
    ¿ø°Å¸® ±¸¿ª
  • field
    ±¸¿ª, ¾ß, ¿µ¿ª
    1. ÀÛ¿ë ¿µ¿ª ¶Ç´Â Àå¼Ò³ª °ø°£. 2. Áö½Ä, ¿¬±¸, Á÷¾÷¿¡ À־ÀÇ Àü¹® ºÐ¾ß. 3. ¹ß»ýÇп¡ ÀÖ¾î º¯µ¿ ¿äÀÎÀÇ ¹üÀ§ ³»¿¡¼­ ºÐÈ­ÇÏ´Â ¿µ¿ª.
  • field cancerization
    ±¸¿ª ¾ÏÈ­
  • field echo
    ÀÚÀå ¿¡ÄÚ
  • field inhomogeneity
    ÀÚÀå ºÒ±ÕÀÏ, ÀÚÀå ºÒ±ÕÀϼº
  • field profile
    ÀÚÀå Ãø¸é »ó
  • field strength
    ÀÚÀå ¼¼±â, ÀÚÀå·Â
  • field survey
    ÇöÁö Á¶»ç
  • fringe field
    ÁÖº¯ ¾ß
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
relative scotoma A scotoma in which there is visual depression but not complete loss of light perception.
(05 Mar 2000)
relative sensitivity The sensitivity of a medical screening test as determined by comparison with the same type of test; e.g., sensitivity of a new serological test relative to sensitivity of an established serological test.
(05 Mar 2000)
relative specificity The specificity of a medical screening test as determined by comparison with the same type of test (e.g., specificity of a new serological test relative to specificity of an established serological test).
(05 Mar 2000)
relative value scales Coded listings of physician or other professional services using units that indicate the relative value of the various services they perform. They take into account time, skill, and overhead cost required for each service, but generally do not consider the relative cost-effectiveness. Appropriate conversion factors can be used to translate the abstract units of the relative value scales into dollar fees for each service based on work expended, practice costs, and training costs.
(12 Dec 1998)
relative viscosity The ratio of the viscosity of a solution or dispersion to the viscosity of the solvent or continuous phase.
(05 Mar 2000)
5-year relative survival rate <statistics> The likelihood that a patient will not die from causes associated with his or her cancer for at least 5 years after diagnosis. This is the standard many professionals use when determining someone a survivor of cancer.
(16 Dec 1997)
auditory field The space included within the limits of hearing of a definite sound, as of a tuning fork.
(05 Mar 2000)
bright field illumination <microscopy> The method of lighting the specimen with a solid cone of rays. Transmitted bright field illumination is performed by a substage condenser. Reflected bright field illumination is performed by a vertical illuminator.
Compare: dark field illumination
(05 Aug 1998)
bright field imaging <microscopy> An imaging mode in a transmission electron microscopy that uses only unscattered Electrons to form the image. Contrast in such an image is due entirely to mass-thickness variations in amorphous samples, and may include diffraction contrast in crystalline samples.
(05 Aug 1998)
bright field microscopy <technique> Optical microscopy, in which absorption to a great extent and diffraction to a minor extent give rise to the image, as opposed to phase contrast or interference methods of microscopy.
(18 Nov 1997)
Broca's field The posterior part of the inferior frontal gyrus of the left or dominant hemisphere, corresponding approximately to Brodmann's area 44; Broca identified this region as an essential component of the motor mechanisms governing articulated speech.
Synonym: Broca's area, Broca's field, motor speech centre.
(05 Mar 2000)
cardioid dark field condenser <microscopy> A condenser designed with two reflecting surfaces, the first, a spherical surface which reflects the rays to a second, cardioid (heart-shaped) surface. The virtue in such an arrangement is that, if the cardioid surface is of true figure, the lens is both achromatic and aplanatic. It has a limiting numerical aperture of about 1.0. Thus objectives of a greater numerical aperture cannot be used successfully with it. A true cardioid figure is the trace of a point on the circumference of a circle rolling around an equal, fixed circle.
(05 Aug 1998)
magnetic field The sphere of influence of a magnet.
(05 Mar 2000)
magnetic field gradient In magnetic resonance imaging, a magnetic field that varies with location, superimposed on the uniform field of the magnet, to alter the resonant frequency of nuclei and allow recovery of their spatial position.
Synonym: field gradient.
(05 Mar 2000)
paraboloid dark field condenser <microscopy> A lens of parabolic shape. The vertex end is ground back so that its focus can be brought into coincidence with the specimen on the slide. A central stop is provided to block the central rays. It is used chiefly for medium- power work.
(05 Aug 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • brick field
    º®µ¹°øÀå
  • center field
    ¼¾ÅÍ(ÀÇ ¼öºñÀ§Ä¡)
  • dark field
    (Çö¹Ì°æÀÇ) ¾Ï½Ã¾ß
  • dark field illumination
    ¾Ï½Ã¾ß Á¶¸í¹ý(Çö¹Ì°æ ½Ã·áÀÇ)
  • dark field microscope
    (±¤)ÇÑ¿Ü Çö¹Ì°æ;¾Ï½Ã¾ß Çö¹Ì°æ
  • electric field
    Àü°è
  • field
    µé;¹úÆÇ;¹ç;±¤Àå;Ç¥¸é;»êÁö;½Î¿òÅÍ;°æ±âÀå;³»(¿Ü)¾ß;ºÐ¾ß;¹ÙÅÁ;¿µ»ó¸é(coal field źÀü)
  • field allowance
    ÃâÁ¤ ¼ö´ç
  • field amvulance
    À̵¿¾ßÀüº´¿ø
  • field army
    ¾ßÀü±º
  • field artillery
    ¾ßÆ÷;¾ßÀüÆ÷º´
  • field bag
    =MUSETTE (BAG)
  • field battery
    ¾ßÆ÷´ë;¾ßÀüÆ÷º´ Áß´ë
  • field book
    Ãø·®ÀÚÀÇ ¾ß¿Ü ¼öø;äÁý ¸Þ¸ðÀå
  • field boot
    ¹«¸­±îÁö ¿À´Â ±ºÈ­
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á